Distribution study of orally administered lipoic acid in rat brain tissues

被引:41
作者
Chng, H. T. [1 ]
New, L. S. [1 ]
Neo, A. H. [2 ]
Goh, C. W. [2 ]
Browne, E. R. [2 ]
Chan, E. C. Y. [1 ]
机构
[1] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore
[2] BGSK Neurol CEDD Cognit & Neurodegenerat Ctr, Singapore 138667, Singapore
关键词
Lipoic acid; Blood-brain barrier; Endogenous; Distribution; Alzheimer's disease; Pharmacokinetics; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; HEALTHY-VOLUNTEERS; TREATMENT OPTION; THIOCTIC ACID; METABOLISM; PLASMA; PHARMACOKINETICS; FORMULATIONS; PROTECTS;
D O I
10.1016/j.brainres.2008.11.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lipoic acid (LA), an essential cofactor for mitochondrial enzymes and a natural antioxidant, has been explored for the treatment of Alzheimer's disease. However, lipoic acid distribution in brain has not been investigated via oral dosing in human subjects or animals. Therefore, we aim to investigate the distribution of orally administered LA from systemic circulation into rat brain tissues and understand the transport efficiency of lipoic acid across the blood-brain barrier. Brain and blood samples were obtained from male Lister Hooded rats at pre-defined time points after single and chronic oral dosing of LA at 50 mg/kg. Levels of LA were determined using liquid chromatography tandem mass spectrometry. An equilibrium dialysis method was employed to elucidate LA protein binding in brain and blood tissues. Basal endogenous levels of LA in control rats were found to fluctuate between 0.005 and 0.267 mu M in blood and 0-0.024 mu M in brain after correction for residual blood volume. Pharmacokinetic profiling demonstrated rapid biphasic elimination of LA in blood and poor distribution into various brain regions with levels ranging from 0.0009 to 0.0072 mu M. The in vitro and in vivo LA brain:blood partition ratios were 0.1 and -0.01, respectively. Our results demonstrate for the first time that LA does not cross the blood-brain barrier readily and suggest that the antioxidant effect of LA in brain may not be due to its direct effect in the central nervous system. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 33 条
[1]   Effect of DL-α-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats [J].
Arivazhagan, P ;
Shila, S ;
Kumaran, S ;
Panneerselvam, C .
EXPERIMENTAL GERONTOLOGY, 2002, 37 (06) :803-811
[2]  
ARIVAZHAGAN P, 2000, PHARM RES, V41, P209
[3]   The pharmacology of the antioxidant lipoic acid [J].
Biewenga, GP ;
Haenen, GRMM ;
Bast, A .
GENERAL PHARMACOLOGY, 1997, 29 (03) :315-331
[4]   PHARMACOLOGICAL STUDIES WITH SK AND F-93944 (TEMELASTINE), A NOVEL HISTAMINE H-1-RECEPTOR ANTAGONIST WITH NEGLIGIBLE ABILITY TO PENETRATE THE CENTRAL-NERVOUS-SYSTEM [J].
BROWN, EA ;
GRIFFITHS, R ;
HARVEY, CA ;
OWEN, DAA .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (03) :569-578
[5]  
GROGLER KB, 1999, EUR J PHARM SCI, V8, P57
[6]  
Hager K, 2007, J NEURAL TRANSM-SUPP, P189
[7]   Alpha-lipoic acid as a new treatment option for Azheimer type dementia [J].
Hager, K ;
Marahrens, A ;
Kenklies, M ;
Riederer, P ;
Münch, G .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2001, 32 (03) :275-282
[8]   METABOLISM OF DL-[1, 6-C-14]LIPOIC ACID IN RAT [J].
HARRISON, EH ;
MCCORMICK, DB .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1974, 160 (02) :514-522
[9]   Enantioselective pharmacokinetics and bioavailability of different racemic alpha-lipoic acid formulations in healthy volunteers [J].
Hermann, R ;
Niebch, G ;
Borbe, HO ;
FiegerBuschges, H ;
Ruus, P ;
Nowak, H ;
RiethmullerWinzen, H ;
Peukert, M ;
Blume, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 4 (03) :167-174
[10]   Lipoic acid as a novel treatment for Alzheimer's disease and related dementias [J].
Holmquist, Lina ;
Stuchbury, Grant ;
Berbaum, Katrin ;
Muscat, Sonja ;
Young, Simon ;
Hager, Klaus ;
Engel, Juergen ;
Munch, Gerald .
PHARMACOLOGY & THERAPEUTICS, 2007, 113 (01) :154-164